Table 4 Risk factors for complications of early endoscopy.

From: Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients

Variables

OR (95% CI)

p-value

Stent re-thrombosis within 6 months

Discontinuation of all anti-platelet

5.25 (1.21–22.74)

0.027

Minor/major complications after EE

Age

0.93 (0.83–1.05)/0.62 (0.17–2.30)

0.251/0.474

Male sex

3.50 (1.15–10.63)/4.25 (1.43–12.63)

0.027/0.009

BMI

0.96 (0.70–1.33)/1.05 (0.60–1.89)

0.821/0.873

Timing between EE to UGIB

1.02 (0.99–1.05)/0.85 (0.62–1.15)

0.264/0.284

TIMI score

0.96 (0.62–1.47)/1.64 (0.71–2.37)

0.839/0.243

APACHE-II score

1.05 (0.94–1.18)/1.13 (0.92–1.40)

0.385/0.244

Rockall score

0.92 (0.60–1.41)/1.07 (0.49–2.36)

0.705/0.861

Blatchford score

1.04 (0.82–1.32)/1.66 (0.75–3.68)

0.739/0.209

  1. APACHE-II Acute Physiology and Chronic Health Evaluation-II, BMI body mass index, EE early endoscopy, TIMI Thrombolysis In Myocardial Infarction, UGIB upper gastrointestinal tract bleeding.
Back to article page